Literature DB >> 12893400

Essential tremor: differential diagnosis and current therapy.

Rajesh Pahwa1, Kelly E Lyons.   

Abstract

Essential tremor is a common movement disorder that affects between 5 and 10 million persons in the United States. It is characterized primarily by an action and postural tremor most often affecting the arms, but it can also affect other body parts. Essential tremor is a progressive neurologic disorder and can cause substantial disability in some patients. Although there is no cure for essential tremor, pharmacologic and surgical treatments can provide some benefit. Primidone and propranolol are first-line treatments. Other medications with potential efficacy include benzodiazepines, gabapentin, topiramate, and botulinum toxin. Patients with medication-resistant tremor may benefit from thalamotomy or deep brain stimulation of the thalamus. The use of medical and surgical therapies can provide benefit in up to 80% of patients with essential tremor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893400     DOI: 10.1016/s0002-9343(03)00259-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  21 in total

1.  Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.

Authors:  Masato Hara; Ryuichi Fukui; Eriko Hieda; Mahomi Kuroiwa; Helen S Bateup; Tatsuhiko Kano; Paul Greengard; Akinori Nishi
Journal:  J Neurochem       Date:  2010-03-04       Impact factor: 5.372

Review 2.  Pharmacotherapy of essential tremor : an overview of existing and upcoming agents.

Authors:  Kelly E Lyons; Rajesh Pahwa
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

3.  The rs2228570 Variant of the Vitamin D Receptor Gene is Associated with Essential Tremor.

Authors:  Ali Sazci; Nihal Uren; Halil Atilla Idrisoglu; Emel Ergul
Journal:  Neurosci Bull       Date:  2018-09-17       Impact factor: 5.203

4.  Deletion of Class II ADP-Ribosylation Factors in Mice Causes Tremor by the Nav1.6 Loss in Cerebellar Purkinje Cell Axon Initial Segments.

Authors:  Nobutake Hosoi; Koji Shibasaki; Mayu Hosono; Ayumu Konno; Yo Shinoda; Hiroshi Kiyonari; Kenichi Inoue; Shin-Ichi Muramatsu; Yasuki Ishizaki; Hirokazu Hirai; Teiichi Furuichi; Tetsushi Sadakata
Journal:  J Neurosci       Date:  2019-06-14       Impact factor: 6.167

5.  Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice.

Authors:  Jason E Kralic; Hugh E Criswell; Jessica L Osterman; Todd K O'Buckley; Mary E Wilkie; Douglas B Matthews; Kristin Hamre; George R Breese; Gregg E Homanics; A Leslie Morrow
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 6.  Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.

Authors:  Cecilie Johannessen Landmark
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

7.  Short pauses in thalamic deep brain stimulation promote tremor and neuronal bursting.

Authors:  Brandon D Swan; David T Brocker; Justin D Hilliard; Stephen B Tatter; Robert E Gross; Dennis A Turner; Warren M Grill
Journal:  Clin Neurophysiol       Date:  2015-08-20       Impact factor: 3.708

Review 8.  Alprazolam for essential tremor.

Authors:  Elisa Bruno; Alessandra Nicoletti; Graziella Quattrocchi; Graziella Filippini; Mario Zappia; Carlo Colosimo
Journal:  Cochrane Database Syst Rev       Date:  2015-12-06

9.  Effects of ramped-frequency thalamic deep brain stimulation on tremor and activity of modeled neurons.

Authors:  Brandon D Swan; David T Brocker; Robert E Gross; Dennis A Turner; Warren M Grill
Journal:  Clin Neurophysiol       Date:  2019-12-26       Impact factor: 3.708

Review 10.  Deep brain stimulation and tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.